Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seasonal Influenza, Vaccine”

285 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 285 results

Testing effectiveness (Phase 2)Study completedNCT00748813
What this trial is testing

Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009

Who this might be right for
Seasonal Influenza
Novartis Vaccines 133
Large-scale testing (Phase 3)Study completedNCT01439360
What this trial is testing

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

Who this might be right for
Influenza
GlaxoSmithKline 12,046
Post-approval studies (Phase 4)Study completedNCT01196026
What this trial is testing

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

Who this might be right for
Influenza
GlaxoSmithKline 162
Testing effectiveness (Phase 2)Study completedNCT01625689
What this trial is testing

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Who this might be right for
Influenza
PATH Vaccine Solutions 309
Testing effectiveness (Phase 2)Study completedNCT05981846
What this trial is testing

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Who this might be right for
SARS CoV 2 InfectionInfluenza, Human
Hipra Scientific, S.L.U 279
Not applicableNot Yet RecruitingNCT07767019
What this trial is testing

Climate Change Trends and Their Impact on the Seasonal Upper Respiratory Tract Disease Burden

Who this might be right for
Upper Resp Tract Infection
Barzilai Medical Center 5,000
Post-approval studies (Phase 4)Study completedNCT03163342
What this trial is testing

Immune Response Following Seasonal Influenza Vaccination

Who this might be right for
Influenza
Altimmune, Inc. 20
Post-approval studies (Phase 4)Study completedNCT03688620
What this trial is testing

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,060
Large-scale testing (Phase 3)Study completedNCT01209780
What this trial is testing

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

Who this might be right for
Seasonal Influenza
Novartis Vaccines 3,116
Not applicableStudy completedNCT01224301
What this trial is testing

School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities

Who this might be right for
ImmunizationsVaccinationInfluenza+1 more
Monroe County Department of Public Health 25,366
Large-scale testing (Phase 3)Study completedNCT02369341
What this trial is testing

Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above

Who this might be right for
Influenza
GlaxoSmithKline 121
Testing effectiveness (Phase 2)Study completedNCT04956575
What this trial is testing

MRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

Who this might be right for
Seasonal Influenza
ModernaTX, Inc. 885
Post-approval studies (Phase 4)Study completedNCT01063608
What this trial is testing

Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.

Who this might be right for
Influenza A Virus, H1N1 Subtype
Institut National de la Santé Et de la Recherche Médicale, France 147
Large-scale testing (Phase 3)Study completedNCT03390166
What this trial is testing

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Who this might be right for
Influenza
Mahidol University 945
Not applicableStudy completedNCT01408290
What this trial is testing

Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 256
Post-approval studies (Phase 4)Study completedNCT01404182
What this trial is testing

Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 121
Not applicableStudy completedNCT03278067
What this trial is testing

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

Who this might be right for
Influenza, Human
GlaxoSmithKline 23,939
Large-scale testing (Phase 3)Study completedNCT01161264
What this trial is testing

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects

Who this might be right for
Seasonal Influenza
Novartis Vaccines 126
Testing effectiveness (Phase 2)Study completedNCT00956449
What this trial is testing

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects

Who this might be right for
InfluenzaSeasonal Influenza
Novartis 126
Testing effectiveness (Phase 2)Study completedNCT01014806
What this trial is testing

Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults

Who this might be right for
Influenza
Novavax 467
Next Page